Scott J. Rodig
Impact in
- Oncology top 0.02%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Viral-associated cancers and disorders
- Immunology top 0.05%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 161
- Cancer Immunotherapy and Biomarkers 79
- CAR-T cell therapy research 37
- Co-authors
- Margaret A. Shipp (62 shared papers)Bjoern Chapuy (33 shared papers)Gordon J. Freeman (30 shared papers)Philippe Armand (26 shared papers)Donna Neuberg (26 shared papers)Robert D. Schreiber (5 shared papers)Pasi A. Jänne (10 shared papers)Lucian R. Chirieac (8 shared papers)
- Journals
- Blood (54 papers)Journal of Clinical Oncology (39 papers)Cold Spring Harbor Protocols (18 papers)Clinical Cancer Research (16 papers)Cancer Immunology Research (13 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Scott J. Rodig
329 papers receiving 33.8k citations
Scott J. Rodig's Hit Papers
Peers
Comparison fields: 5 of 149
- Oncology 16.1k
- Immunology 9.9k
- Pathology and Forensic Medicine 7.4k
- Genetics 3.5k
- Cancer Research 3.6k
Countries citing papers authored by Scott J. Rodig
This map shows the geographic impact of Scott J. Rodig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott J. Rodig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott J. Rodig more than expected).
Fields of papers citing papers by Scott J. Rodig
This network shows the impact of papers produced by Scott J. Rodig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott J. Rodig. The network helps show where Scott J. Rodig may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott J. Rodig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 349 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma Hit paper breakdown → | 2014 | 2687 |
| 2 | Comprehensive analyses of tumor immunity: implications for cancer immunotherapy Hit paper breakdown → | 2016 | 1644 |
| 3 | Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK Hit paper breakdown → | 2009 | 1469 |
| 4 | Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway Hit paper breakdown → | 1996 | 1414 |
| 5 | Adaptive immunity maintains occult cancer in an equilibrium state Hit paper breakdown → | 2007 | 1026 |
| 6 | Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma Hit paper breakdown → | 2010 | 939 |
| 7 | MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia Hit paper breakdown → | 2012 | 807 |
| 8 | Disruption of the Jak1 Gene Demonstrates Obligatory and Nonredundant Roles of the Jaks in Cytokine-Induced Biologic Responses Hit paper breakdown → | 1998 | 675 |
| 9 | PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies Hit paper breakdown → | 2013 | 666 |
| 10 | Tet1 and Tet2 Regulate 5-Hydroxymethylcytosine Production and Cell Lineage Specification in Mouse Embryonic Stem Cells Hit paper breakdown → | 2011 | 610 |
| 11 | Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor Hit paper breakdown → | 2010 | 608 |
| 12 | PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome Hit paper breakdown → | 2016 | 563 |
| 13 | Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma Hit paper breakdown → | 2013 | 560 |
| 14 | Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy Hit paper breakdown → | 2012 | 559 |
| 15 | Unique Clinicopathologic Features Characterize ALK -Rearranged Lung Adenocarcinoma in the Western Population Hit paper breakdown → | 2009 | 528 |
| 16 | Association of Polymerase e–Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1 Hit paper breakdown → | 2015 | 525 |
| 17 | Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma Hit paper breakdown → | 2012 | 489 |
| 18 | Immunological mechanisms of the antitumor effects of supplemental oxygenation Hit paper breakdown → | 2015 | 486 |
| 19 | Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer Hit paper breakdown → | 2016 | 456 |
| 20 | The biology and treatment of EML4-ALK non-small cell lung cancer Hit paper breakdown → | 2010 | 425 |
About Scott J. Rodig
Scott J. Rodig is a scholar working on Oncology, Molecular Biology, Pathology and Forensic Medicine, Immunology and Pulmonary and Respiratory Medicine, having authored 349 papers that have together received 34.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (79 papers), Lymphoma Diagnosis and Treatment (79 papers), CAR-T cell therapy research (37 papers), Immunotherapy and Immune Responses (33 papers), Immune Cell Function and Interaction (32 papers), Chronic Lymphocytic Leukemia Research (26 papers), Cancer Genomics and Diagnostics (22 papers) and Lung Cancer Treatments and Mutations (20 papers). The work is most often cited by research in Oncology (16.1k citations), Immunology (9.9k citations), Pathology and Forensic Medicine (7.4k citations), Genetics (3.5k citations) and Cancer Research (3.6k citations). Scott J. Rodig has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Margaret A. Shipp, Bjoern Chapuy, Gordon J. Freeman, Philippe Armand, Donna Neuberg, Robert D. Schreiber, Pasi A. Jänne, Lucian R. Chirieac, Jeffery L. Kutok and Heather H. Sun. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cold Spring Harbor Protocols, Clinical Cancer Research and Cancer Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.